Managing Chemotherapy Induced Anemia With Darbepoetin Alfa and Other Erythropoiesis Stimulating Agents: A Nurse's Perspective

Nursing: Research and Reviews
doi 10.2147/nrr.s49399
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Anemia Treatment With Q2W Darbepoetin Alfa in Patients With Chronic Kidney Disease Naïve to Erythropoiesis-Stimulating Agents

Current Medical Research and Opinion
Medicine
2008English

PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Darbepoetin Alpha in the Treatment of Cancer Chemotherapy-Induced Anemia

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2007English

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update

Journal of Oncology Practice
Health PolicyOncology
2019English

Treatment Options for Anemia, Taking Risks Into Consideration: Erythropoiesis-Stimulating Agents Versus Transfusions

Oncologist
Cancer ResearchMedicineOncology
2008English

Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients With Cancer- Or Chemotherapy-Induced Anemia

Oncology
MedicineCancer ResearchOncology
2011English

Pcn179 - The Comparative Pharmacoeconomic Analysis of Using Different Erythropoiesis-Stimulantig Agents for Managing Chemotherapy-Induced Anemia in Adult Cancer Patients in Actual Practice in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Beneficial Effect of High Dose Darbepoetin-Alfa in Peritoneal Dialysis Patients With Renal Anemia

Nihon Toseki Igakkai Zasshi
2010English

Budget Impact Analysis of Darbepoetin Alfa Every 3 Weeks Versus Epoetin Alfa Every Week for Cancer Patients Receiving Chemotherapy From a Us Payer's Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy